Sasanlimab in combination with Bacillus Calmette-Guérin improves event-free survival versus Bacillus Calmette-Guérin as standard of care in high-risk non-muscle-invasive bladder cancer: Phase 3 CREST study results
Web preview is not available
Try directly downloading the file.